Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Bristol-myers squibb company crawled date : 2020 - 12 - 11 save search
Bristol Myers Squibb Announces Settlement of U.S. Patent Litigation for REVLIMID® (lenalidomide) with Cipla
Published: 2020-12-11 (Crawled : 16:00) - biospace.com/
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
|
| O: 0.22%
H: 1.89%
C: 0.65%
patent
Cipla Announces Settlement of REVLIMID® (lenalidomide) Capsules Patent Litigation
Published: 2020-12-11 (Crawled : 16:00) - biospace.com/
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
|
| O: 0.22%
H: 1.89%
C: 0.65%
patent
Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic® (fedratinib) for Adult Patients with Newly Diagnosed and Previously Treated Myelofibrosis
Published: 2020-12-11 (Crawled : 15:00) - biospace.com/
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
|
| O: 0.22%
H: 1.89%
C: 0.65%
positive chmp
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.